Steris Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Steris Plc on April 6, 2026, covering events occurring on March 31, 2026. The registrant is incorporated in Ireland and trades on the New York Stock Exchange under the symbol STE.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements and does not contain financial performance data.
Material Changes
The primary material change reported is an amendment to the Transition Agreement with Michael J. Tokich, the Company's former Chief Financial Officer. Key changes include:
- Extension of Mr. Tokich's role as a senior financial advisor on a part-time basis from April 1, 2026, through March 31, 2027.
- Reduction of annual base salary to $60,000 during the extended period.
- Eligibility for a cash bonus at the discretion of the CEO, subject to committee approval.
- Termination of entitlement to health, dental, life insurance, vacation, disability, and other employee benefit plans.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. The document is limited to the disclosure of the amended compensatory arrangement.
Key Facts for Investor Verification
- Verify the total cost impact of the extended advisor period on the company's operating expenses.
- Confirm the status of the search for a permanent replacement for the Chief Financial Officer role.
- Review the specific terms of the cash bonus eligibility to understand potential variable compensation exposure.